Market revenue in 2023 | USD 2.0 million |
Market revenue in 2030 | USD 11.2 million |
Growth rate | 27.5% (CAGR from 2023 to 2030) |
Largest segment | Drug optimization & repurposing |
Fastest growing segment | Drug Optimization & Repurposing |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Drug Optimization & Repurposing, Preclinical Testing |
Key market players worldwide | International Business Machines Corp, Exscientia PLC ADR, Alphabet Inc Class A, Benevolent AI, Recursion Pharmaceuticals Inc Class A, Aitia, BioSymetrics, Euretos, Berg, Atomwise, Insitro |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to artificial intelligence in drug discovery market will help companies and investors design strategic landscapes.
Drug optimization & repurposing was the largest segment with a revenue share of 55% in 2023. Horizon Databook has segmented the Saudi Arabia artificial intelligence in drug discovery market based on drug optimization & repurposing, preclinical testing covering the revenue growth of each sub-segment from 2018 to 2030.
The adoption of AI in drug discovery is increasing in the country owing to several factors, including awareness about the potential of AI in reimagining drug discovery, a surge in demand to reduce time for drug discovery & development.
Increasing investments to drive the adoption of AI in the country. For instance, in October 2020, The University of Oxford entered into a partnership with King Abdulaziz University (KAU) for discovering novel treatments for rare genetic conditions and common diseases.
The Kingdom of Saudi Arabia has further prioritized digital technologies and AI tools for creating & planning the future as a part of Saudi Vision 2030.
Horizon Databook provides a detailed overview of country-level data and insights on the Saudi Arabia artificial intelligence in drug discovery market , including forecasts for subscribers. This country databook contains high-level insights into Saudi Arabia artificial intelligence in drug discovery market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account